Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

SLC17A2 Inhibitors

SLC17A2 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the SLC17A2 protein, a member of the solute carrier family. SLC17A2 is part of the larger SLC17 family, which is known for its role in transporting organic anions, including neurotransmitters and other small molecules, across cellular membranes. The inhibition of SLC17A2 can disrupt the transport processes it mediates, offering researchers a powerful tool to study the protein's function and its broader impact on cellular activities. By selectively inhibiting SLC17A2, scientists can explore how this transporter influences the distribution and concentration of specific anions within cells, and how these changes affect cellular metabolism and signaling.

The use of SLC17A2 inhibitors in research is particularly valuable for dissecting the role of this transporter in various biological systems. By blocking SLC17A2 activity, researchers can observe the resulting alterations in cellular processes, such as changes in ion gradients, neurotransmitter release, and intracellular signaling pathways. These studies help to elucidate the specific substrates transported by SLC17A2 and the physiological contexts in which this transporter is most active. Additionally, SLC17A2 inhibitors can be used to explore the regulatory mechanisms that control the expression and activity of this protein, providing insights into how cells maintain homeostasis in response to environmental and intracellular cues. Through these investigations, SLC17A2 inhibitors contribute to a deeper understanding of membrane transport mechanisms and the complex interplay between transport proteins and cellular function.

SEE ALSO...

Items 11 to 19 of 19 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Probenecid

57-66-9sc-202773
sc-202773A
sc-202773B
sc-202773C
1 g
5 g
25 g
100 g
$28.00
$39.00
$100.00
$277.00
28
(2)

Competitively inhibits various anion transporters, potentially reducing the function of SLC17 family members.

Phloridzin

60-81-1sc-219613
2.5 g
$396.00
(0)

Inhibits sodium-dependent transporters, might reduce competitive uptake of phosphate.

Indomethacin

53-86-1sc-200503
sc-200503A
1 g
5 g
$29.00
$38.00
18
(1)

Inhibits anion transporters indirectly by affecting prostaglandin synthesis, altering renal transport dynamics.

Furosemide

54-31-9sc-203961
50 mg
$41.00
(1)

A loop diuretic that inhibits the NKCC2, can have secondary effects on phosphate transport.

Bumetanide (Ro 10-6338)

28395-03-1sc-200727
sc-200727A
1 g
5 g
$109.00
$228.00
9
(1)

Similar to Furosemide, inhibits NKCC2 which could indirectly influence SLC17A activity.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Affects inositol monophosphatase leading to changes in anion transport, could alter SLC17A function.

Clofibrate

637-07-0sc-200721
1 g
$33.00
(1)

Alters lipid metabolism and can influence membrane transporters by modifying membrane properties.

Hydrochlorothiazide

58-93-5sc-207738
sc-207738A
sc-207738B
sc-207738C
sc-207738D
5 g
25 g
50 g
100 g
250 g
$55.00
$240.00
$333.00
$562.00
$988.00
(0)

A thiazide diuretic that affects electrolyte reabsorption, could indirectly affect SLC17A-related transport.

Chlorothiazide

58-94-6sc-202536
sc-202536A
sc-202536B
1 g
5 g
10 g
$39.00
$107.00
$175.00
(0)

Similar to Hydrochlorothiazide, could have an indirect effect on SLC17A activity by altering ion balance.